HIGHLIGHTS
- who: Item Type and colleagues from the of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio, USAKumamoto University have published the paper: Differential role of MLKL in alcohol-associated and non- alcohol-associated fatty liver diseases in mice and humans, in the Journal: (JOURNAL) of May/18,/2020
- what: The authors show here that differential role for mixed-lineage kinase domain-like protein (MLKL) the downstream effector of RIP3 in murine models of ALD versus NAFL/NASH and that RIP1-RIP3-MLKL can be used as biomarkers to distinguish alcohol-associated hepatitis (AH) from NASH.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.